Literature DB >> 6273022

Prolonged remission in florid Cushing's syndrome following metyrapone treatment.

C G Beardwell, A R Adamson, S M Shalet.   

Abstract

Two patients presenting with diabetes mellitus and hypokalaemia resulting from markedly increased ACTH and cortisol secretion are described. Neither patient showed any evidence of a tumour and both responded dramatically to treatment with metyrapone in that all abnormal clinical features disappeared, ACTH concentrations returned to normal and both patients showed prolonged remission after metyrapone treatment was stopped. One patient relapsed after a severe viral illness and the administration of dexamethasone and cortisone. It is suggested that these cases may represent an unusual form of Cushing's syndrome in which ACTH secretion is stimulated by increasing concentrations of cortisol. When these are reduced by metyrapone administration ACTH secretion falls in parallel and prolonged remission of disease may result.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273022     DOI: 10.1111/j.1365-2265.1981.tb00638.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

2.  Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells.

Authors:  Aura D Herrera-Martínez; Richard A Feelders; Wouter W de Herder; Justo P Castaño; María Ángeles Gálvez Moreno; Fadime Dogan; Rosanna van Dungen; Peter van Koetsveld; Leo J Hofland
Journal:  Horm Cancer       Date:  2019-05-18       Impact factor: 3.869

3.  Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.

Authors:  S T Sharma; L K Nieman
Journal:  Eur J Endocrinol       Date:  2011-12-21       Impact factor: 6.664

Review 4.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

Review 5.  ACTH Antagonists.

Authors:  Adrian John Clark; Rachel Forfar; Mashal Hussain; Jeff Jerman; Ed McIver; Debra Taylor; Li Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-05       Impact factor: 5.555

6.  Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.

Authors:  Hideyuki Iwayama; Sho Hirase; Yuka Nomura; Tatsuo Ito; Hiroyuki Morita; Kazuo Otake; Akihisa Okumura; Junko Takagi
Journal:  BMC Endocr Disord       Date:  2018-03-27       Impact factor: 2.763

7.  Cushing Disease After Treatment of Nonfunctional Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Hongjuan Fang; Rui Tian; Huanwen Wu; Jian Xu; Hong Fan; Jian Zhou; Liyong Zhong
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.